Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

PURPOSE: Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients wi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, Jung Hwan, Oh, Sung Yong, Kwon, Hyuk-Chan, Lee, Suee, Kim, Sung-Hyun, Kim, Dae-Cheol, Lee, Jin-Hwa, Lee, Hyung-Sik, Cho, Se-Heun, Kim, Hyo-Jin
Formato: Artigo
Idioma:Inglês
Publicado: Korean Cancer Association 2008
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697461/
https://ncbi.nlm.nih.gov/pubmed/19688114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.3.101
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares